Research & Publications

Cell & Gene Pipeline Outlook: January 2026

Tracking the therapies shaping tomorrow’s care

cover image for Cell & Gene Pipeline Outlook: January 2026

Prime Therapeutics’ Cell & Gene Pipeline Outlook is an industry report that explores emerging trends, innovations, and market dynamics shaping cell and gene therapy. It delivers expert analysis and forward-looking insights to help stakeholders anticipate changes and make informed decisions. 

Read more

About Prime Therapeutics

Prime Therapeutics logo

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn

Latest News